Renewal of annual software licenses for tibco spotfire and columbus software
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00659
- Awardee
-
Revvity Signals Software, Inc. UEI YJRFVQ6WNJV7 Part of Revvity Inc.
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $396,021
Award facts
- Opportunity
-
- Renewal of Annual Software licenses for TIBCO Spotfire and Columbus software Special Notice · 75N95021Q00382 · Posted Sep 1, 2021
- Contract value 59% obligated
-
- $396,021.00 Current, with exercised options
- $667,327.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541511 Custom Computer Programming Services
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Westlake, MD 20817, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $129,686 | |
| Exercise an Option | $125,827 | |
| Other Administrative Action | $0 | |
| Original award | $140,508 |
About this award
This is a $667,327.00 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Revvity Signals Software, Inc. The contract is for the renewal of annual software licenses for TIBCO Spotfire and Columbus software, which are used for data visualization and analytics across various disciplines at NCATS. The contract has a five-year period of performance from September 27, 2021 to September 26, 2026. Revvity Signals Software, Inc. is a subsidiary of the parent company Revvity Inc. Medical Imaging, LLC, which has a history of providing software solutions and services to federal agencies, including the Department of Commerce, USDA, and other NIH institutes.
Quick answers
Who was awarded contract 75N95021P00659?
75N95021P00659 was awarded to Revvity Signals Software, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2021.
How much is contract 75N95021P00659 worth?
The government has obligated $396,021 on 75N95021P00659. Its potential value, with all options, is $667,327.
Which agency awarded contract 75N95021P00659?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00659, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00659 competed?
The extent of competition for 75N95021P00659 was not available for competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award